RESUMEN
OBJECTIVE: To investigate if the presence of metallic markers (markers) influences the diagnostic accuracy of preoperative breast MRI for the prediction of pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer patients. MATERIALS AND METHODS: In this single-center, retrospective, observational study approved by the IRB of our institution, we included all consecutive patients that underwent preoperative breast MRI after completion of NAC (Mean 4,4 days ± 15,9). The presence or absence of markers, the type of markers, the size and type of artefact on each MRI sequence were recorded. Two radiologists blinded to histopathological results and to each other's findings evaluated all MRI examinations for presence or absence of complete response. Pathology was the standard of reference. Diagnostic performance of MRI for prediction of pCR in the presence or absence of markers and also between two most represented markers brands (O'Twist and UltraClip) were compared using Chi-squared tests or equivalents. RESULTS: Ninety-three patients (mean age 48 ± 11 years) were included in this study. Nineteen of them had no markers and 74 had 108 markers. Sensitivity and specificity of MRI for the prediction of pCR were 0.73 and 0,81 for patients with and 0.67 and 0.90 for patients without markers (p < 0.05).There was no statistical difference in the performance of MRI for the two different types of markers studied. CONCLUSION: Diagnostic performance of pre-operative MRI after NAC for the prediction of pCR did not differ statistically in the presence or absence of metallic markers nor between the two markers' brands studied.